Trial NCT04502576
Publication Grieco DL, JAMA, 2021
Primary outcome on the report: Number of days free of respiratory support (including high-flow nasal oxygen, noninvasive and invasive ventilation) within 28 days after enrollment

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.